| Jun 21 |
Halozyme Announces argenx Receives FDA Approval for VYVGART® Hytrulo Co-Formulated with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy
|
| Jun 21 |
Bristol Myers Opdivo injectable accepted for EU review
|
| Jun 20 |
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
| Jun 15 |
The 3 Best Healthcare Stocks to Buy in June 2024
|
| Jun 14 |
Why Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?
|
| Jun 13 |
Insider Sale: Director Matthew Posard Sells Shares of Halozyme Therapeutics Inc (HALO)
|
| Jun 12 |
Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound?
|
| Jun 11 |
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Downgraded by Piper Sandler
|
| Jun 11 |
Halozyme Therapeutics (HALO) is a Top-Ranked Momentum Stock: Should You Buy?
|
| Jun 9 |
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
|
